Products for Research Use Only
RegisterLogin

GAT229

CAT: 0804-HY-121600-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-121600-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
GAT229 is a CB1 positive allosteric modulator (PAM) that effectively reduces intraocular pressure (IOP) in high IOP mouse models and enhances CB1 receptor-mediated IOP-lowering effects. A 0.2% GAT229 solution or 10 mg/kg of GAT229 alone significantly reduces IOP. GAT229 is promising for research related to glaucoma and elevated intraocular pressure[1].
CAS Number
889860-85-9
UNSPSC
12352005
Target
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/gat229.html
Smiles
O=[N+](C[C@H](C1=C(C2=CC=CC=C2)NC3=C1C=CC=C3)C4=CC=CC=C4)[O-]
Molecular Formula
C22H18N2O2
Molecular Weight
342.39
References & Citations
[1]Cairns EA, et al. The In Vivo Effects of the CB1-Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice. J Ocul Pharmacol Ther. 2017 Oct;33 (8) :582-590.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-120953GAT228
HY-113689-01GAT211
HY-P1105GaTx2
HY-174676Human GATA2 mRNA
HY-P703133GATA2, Human (His, Strep)
HY-P86888-01GATA2+GATA3 Antibody (YA6581, Rabbit)
HY-P83022-01GATA2/3 Antibody (YA2767, Rabbit)
HY-RS05290GATA2 Human Pre-designed siRNA Set A
HY-RS26530Gata2 Rat Pre-designed siRNA Set A
HY-RS20027Gata2 Mouse Pre-designed siRNA Set A

Alternative Products

CatalogName
MBS5802650GAT229

Popular Products